- Home
- Publications
- Publication Search
- Publication Details
Title
Future therapeutic targets in rheumatoid arthritis?
Authors
Keywords
Rheumatoid arthritis, GM-CSF, JAK, BTK, PI3K, Tolerogenic dendritic cells
Journal
Seminars in Immunopathology
Volume 39, Issue 4, Pages 487-500
Publisher
Springer Nature
Online
2017-04-27
DOI
10.1007/s00281-017-0623-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
- (2017) Peter C. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
- (2017) Roy Fleischmann et al. Arthritis & Rheumatology
- Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
- (2016) G M Bell et al. ANNALS OF THE RHEUMATIC DISEASES
- Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2)
- (2016) A Kavanaugh et al. ANNALS OF THE RHEUMATIC DISEASES
- Filgotinib (GLPG0634/GS-6034), an oral JAK1 selective inhibitor, is effective in combination with methotrexate (MTX) in patients with active rheumatoid arthritis and insufficient response to MTX: results from a randomised, dose-finding study (DARWIN 1)
- (2016) R Westhovens et al. ANNALS OF THE RHEUMATIC DISEASES
- Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study
- (2016) Maxime Dougados et al. ANNALS OF THE RHEUMATIC DISEASES
- Idelalisib
- (2016) Pierre Sujobert et al. CANCER JOURNAL
- Investigational Bruton’s tyrosine kinase inhibitors for the treatment of rheumatoid arthritis
- (2016) Peter Norman EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Baricitinib in Patients with Refractory Rheumatoid Arthritis
- (2016) Mark C. Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis
- (2016) Frieda A. Koopman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Idelalisib for the treatment of indolent non-Hodgkin lymphoma: a review of its clinical potential
- (2016) Jacqueline C. Barrientos OncoTargets and Therapy
- Efficacy and Safety of ABT-494, a Selective JAK-1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- (2016) Mark C. Genovese et al. Arthritis & Rheumatology
- A Phase IIb Study of ABT-494, a Selective JAK-1 Inhibitor, in Patients With Rheumatoid Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Therapy
- (2016) Joel M. Kremer et al. Arthritis & Rheumatology
- Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside
- (2016) Md. Selim Ahmed et al. Immune Network
- Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
- (2015) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Idelalisib: First-in-Class PI3K Delta Inhibitor for the Treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, and Follicular Lymphoma
- (2015) Q. Yang et al. CLINICAL CANCER RESEARCH
- Daily practice feasibility and effectiveness of treating long-standing rheumatoid arthritis to target with synthetic disease-modifying antirheumatic drugs: a prospective cohort study
- (2015) Claiton Viegas Brenol et al. CLINICAL RHEUMATOLOGY
- Bone marrow CD11b+F4/80+ dendritic cells ameliorate collagen-induced arthritis through modulating the balance between Treg and Th17
- (2015) Lingling Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naive and TNF-IR Patients with Rheumatoid Arthritis
- (2015) Mark C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate
- (2015) K. Pavelka et al. JOURNAL OF RHEUMATOLOGY
- Efficacy and Safety of Anti-Interleukin-20 Monoclonal Antibody in Patients With Rheumatoid Arthritis: A Randomized Phase IIa Trial
- (2015) Ladislav Šenolt et al. Arthritis & Rheumatology
- Tolerogenic dendritic cells modified by tacrolimus suppress CD4+ T-cell proliferation and inhibit collagen-induced arthritis in mice
- (2014) Yana Ren et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
- (2014) M. C. Genovese et al. JOURNAL OF RHEUMATOLOGY
- Tofacitinib versus Methotrexate in Rheumatoid Arthritis
- (2014) Eun Bong Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase II Randomized Study of Subcutaneous Ixekizumab, an Anti-Interleukin-17 Monoclonal Antibody, in Rheumatoid Arthritis Patients Who Were Naive to Biologic Agents or Had an Inadequate Response to Tumor Necrosis Factor Inhibitors
- (2014) Mark C. Genovese et al. Arthritis & Rheumatology
- Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis
- (2014) Kevin L. Winthrop et al. Arthritis & Rheumatology
- Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis
- (2013) Joel Kremer et al. ANNALS OF INTERNAL MEDICINE
- Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-four-month phase III randomized radiographic study
- (2013) Désirée van der Heijde et al. ARTHRITIS AND RHEUMATISM
- GM-CSF alters dendritic cells in autoimmune diseases
- (2013) Bao-Zhu Li et al. AUTOIMMUNITY
- Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
- (2013) Gerd R Burmester et al. LANCET
- Small molecules targeting JAKs--a new approach in the treatment of rheumatoid arthritis
- (2013) E. Feist et al. RHEUMATOLOGY
- Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis
- (2012) Katja Thiele et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study
- (2012) Mark C Genovese et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
- (2012) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Decisions About Dendritic Cells: Past, Present, and Future
- (2012) Ralph M. Steinman Annual Review of Immunology
- Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?
- (2012) C. M. U. Hilkens et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
- (2012) Roy Fleischmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
- (2012) Ronald F. van Vollenhoven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Goal-directed therapy for RA in routine practice is associated with improved function in patients with disease duration up to 15 years
- (2012) N. J. Gullick et al. RHEUMATOLOGY
- A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry
- (2011) Lydia G Schipper et al. ANNALS OF THE RHEUMATIC DISEASES
- Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study
- (2011) S. A. Provan et al. ANNALS OF THE RHEUMATIC DISEASES
- Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort
- (2011) M. Soubrier et al. ANNALS OF THE RHEUMATIC DISEASES
- Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial
- (2011) I. C. van Eijk et al. RHEUMATOLOGY
- Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor 7 subunit gene knockout mice
- (2010) M. A. van Maanen et al. ANNALS OF THE RHEUMATIC DISEASES
- Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study
- (2010) A. G. Semb et al. ANNALS OF THE RHEUMATIC DISEASES
- Genes on the X chromosome affect development of collagen-induced arthritis in mice
- (2010) L. JANSSON et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The PI3K Isoforms p110 and p110 Are Essential for Pre-B Cell Receptor Signaling and B Cell Development
- (2010) F. Ramadani et al. Science Signaling
- DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis
- (2009) Y P M Goekoop-Ruiterman et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
- (2009) M J L Peters et al. ANNALS OF THE RHEUMATIC DISEASES
- The α7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: A possible role for a key neurotransmitter in synovial inflammation
- (2009) Marjolein A. Van Maanen et al. ARTHRITIS AND RHEUMATISM
- Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice
- (2009) Marjolein A. van Maanen et al. ARTHRITIS AND RHEUMATISM
- Semi-mature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice
- (2009) Dae-Seog Lim et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- PI3Kγ regulates cartilage damage in chronic inflammatory arthritis
- (2009) Silvia Hayer et al. FASEB JOURNAL
- Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
- (2009) Abdalla J. Mohamed et al. IMMUNOLOGICAL REVIEWS
- The Vagus Nerve and Nicotinic Receptors Involve Inhibition of HMGB1 Release and Early Pro-inflammatory Cytokines Function in Collagen-Induced Arthritis
- (2009) Tong Li et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Innate immune recognition of infected apoptotic cells directs TH17 cell differentiation
- (2009) Miriam Beer Torchinsky et al. NATURE
- G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis
- (2009) Ann L. Cornish et al. Nature Reviews Rheumatology
- Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies
- (2009) C. Meune et al. RHEUMATOLOGY
- Cell Specific Synovial Expression of Nicotinic Alpha 7 Acetylcholine Receptor in Rheumatoid Arthritis and Psoriatic Arthritis
- (2009) M. Westman et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Rheumatoid Arthritis Synovium Contains Two Subsets of CD83−DC-LAMP− Dendritic Cells with Distinct Cytokine Profiles
- (2008) M. Cristina Lebre et al. AMERICAN JOURNAL OF PATHOLOGY
- Acetylcholine regulation of synoviocyte cytokine expression by the α7 nicotinic receptor
- (2008) Jean-Marc Waldburger et al. ARTHRITIS AND RHEUMATISM
- Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies
- (2008) J. Antonio Aviña-Zubieta et al. ARTHRITIS AND RHEUMATISM
- The Structure of the GM-CSF Receptor Complex Reveals a Distinct Mode of Cytokine Receptor Activation
- (2008) Guido Hansen et al. CELL
- Sympathetic modulation of immunity: Relevance to disease
- (2008) Denise L. Bellinger et al. CELLULAR IMMUNOLOGY
- GM-CSF in the generation of dendritic cells from human blood monocyte precursors: Recent advances
- (2008) Lucia Conti et al. IMMUNOBIOLOGY
- The p110γ isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites
- (2008) Molly S. Thomas et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma
- (2008) Nandini Krishnamoorthy et al. NATURE MEDICINE
- Spleen Vagal Denervation Inhibits the Production of Antibodies to Circulating Antigens
- (2008) Ruud M. Buijs et al. PLoS One
- Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia
- (2008) M. Rosas-Ballina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
- (2007) W J Jonge et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now